Table 3.
Distribution of companies or institutions developing biodefense products
| Country | Number of firms developing biodefense vaccines | Number of firms developing biodefense therapeutics |
|---|---|---|
| Argentina | 0 | 1 |
| Australia | 2 | 4 |
| Austria | 1 | 0 |
| Belgium | 2 | 2 |
| Canada | 3 | 6 |
| China | 1 | 2 |
| Denmark | 2 | 1 |
| France | 2 | 1 |
| India | 3 | 0 |
| Israel | 2 | 3 |
| Japan | 2 | 5 |
| The Netherlands | 3 | 2 |
| Russia | 1 | 0 |
| Singapore | 1 | 2 |
| South Korea | 2 | 0 |
| Spain | 1 | 0 |
| Sweden | 1 | 0 |
| Switzerland | 1 | 0 |
| Taiwan | 0 | 1 |
| United Kingdom | 7 | 4 |
| United States | 57 | 61 |
| Total | 94 | 95 |
Source: ref. 1.